What are Polysaccharide conjugate vaccine drugs?

Polysaccharide conjugate vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Neisseria meningitidis serogroups A and C polysaccharide capsule). 3 are currently marketed, with 1 more in clinical development.

What are the marketed Polysaccharide conjugate vaccine drugs?

Marketed Polysaccharide conjugate vaccine drugs include A+C Vaccine, Meningococcal A+C vaccine, Meningococcal (vaccine).

Polysaccharide conjugate vaccine

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3 marketed 1 in Phase 3

This page covers all Polysaccharide conjugate vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Neisseria meningitidis serogroups A and C polysaccharide capsule, Neisseria meningitidis serogroups A and C capsular polysaccharides, Neisseria meningitidis capsular polysaccharides and outer membrane proteins.

Targets

Neisseria meningitidis serogroups A and C polysaccharide capsule · Neisseria meningitidis serogroups A and C capsular polysaccharides · Neisseria meningitidis capsular polysaccharides and outer membrane proteins · Meningococcal serogroup A, C, Y, and W-135 polysaccharide capsules

Marketed (3)

A+C Vaccine · Jiangsu Province Centers for Disease Control and Prevention · Immunology / Infectious Disease
A+C Vaccine is a combined meningococcal vaccine that stimulates the immune system to produce antibodies against Neisseria meningitidis serogroups A and C.
Meningococcal A+C vaccine · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroups A and C polysaccharide antigens.
Meningococcal (vaccine) · GlaxoSmithKline · Immunology / Infectious Disease
The meningococcal vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis, preventing meningococcal disease.

Phase 3 pipeline (1)

Meningococcal ACYW135 Polysaccharide Conjugate Vaccine · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Immunology / Infectious Disease
This vaccine stimulates the immune system to produce antibodies against meningococcal serogroups A, C, Y, and W-135 by presenting conjugated polysaccharide antigens.

Patent intelligence

polysaccharide conjugate vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates